GANYMED raises Euro 33.7 Million in Series C Financing Round
GANYMED Pharmaceuticals AG, a privately held cancer antibody company, has closed a Series C financing round totaling Eur…
GANYMED Pharmaceuticals AG, a privately held cancer antibody company, has closed a Series C financing round totaling Eur…
/pressemitteilung/pdf/89467/meldung.pdf
In future, Höft & Wessel AG, Hanover, will once more be lead by an executive board of three members, in order to manage…